A Comparative Study of the Incidence of Adverse Events During Propofol and Sevoflurane Combination Anesthesia Management During intraoperative Motor Evoked Potential in Endovascular Therapy.

A Comparative Study of the Incidence of Adverse Events During Total Intravenous Anesthesia and Sevoflurane Combination Anesthesia Management During Motor Evoked Potential Monitoring in Endovascular Therapy.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1011240035

Enrollment

204

Registered

2024-10-03

Start date

2024-10-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Aneurysm Cerebral aneurysm

Interventions

Total intravenous anesthesia with the addition of sevoflurane for anesthetic management.

D000077149

Sevoflurane

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undergo neuroendovascular therapy using motor evoked potential monitoring.

Exclusion criteria

Exclusion criteria: Patients who are unable to perform adequate MEP monitoring. Patients who are allergic to propofol or sevoflurane. Patients who are deemed by the attending anesthesiologist, principal investigator, or principal study investigator to be ineligible for participation in this study.

Design outcomes

Primary

Measure	Time frame
Incidence of adverse events (body movement, bucking, etc.)	—

Secondary

Measure	Time frame
MEP Monitoring Success Rate Threshold value Amplitude value Latency Circulation (blood pressure, heart rate, etc.)	—

Contacts

Public ContactTomohiro Chaki

Sapporo Medical University School of Medicine Hospital

chakitomohiro0728@yahoo.co.jp+81-90-7051-8560

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026